Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia.

OBJECTIVES: Statins reduce cardiovascular events by cholesterol-lowering as well as nonlipid-related actions. Thrombin activatable fibrinolysis inhibitor (TAFI) is a recently identified independent risk factor of thrombosis. Endothelial dysfunction is also a strong predictor of cardiovascular events...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Guven, Gulay S., Atalar, Enver, Yavuz, Bunyamin, Beyazit, Yavuz, Kekilli, Murat, Kilicarslan, Alparslan, Sahiner, Levent, Oz, Gul, Ozer, Necla, Aksoyek, Serdar, Haznedaroglu, Ibrahim C., Sozen, Tumay
Médium: Artigo
Jazyk:Inglês
Vydáno: National Medical Association 2006
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2569240/
https://ncbi.nlm.nih.gov/pubmed/16623076
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky